SCHEMBL29973253

SCHEMBL29973253

OCc1ccc(Br)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 1/20 0.42
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
LMNA P02545 4/20 0.40
HPGD P15428 4/20 0.40
NPC1 O15118 4/20 0.40
RAB9A P51151 3/20 0.40
ALDH1A1 P00352 2/20 0.40
GAA P10253 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TTR P02766 1/20 0.40
MAPT P10636 3/20 0.39
SLC6A2 P23975 5/20 0.37
SLC6A4 P31645 5/20 0.37
SLC6A3 Q01959 5/20 0.37
CYP3A4 P08684 5/20 0.37
CYP2D6 P10635 4/20 0.37
KCNH2 Q12809 4/20 0.37
HTT P42858 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2522185 1.00 RECQL (0.42) RECQLMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL2299809 0.83 ALDH1A1 (0.47) MEN1KMT2ASMN1; SMN2LMNAHPGD
SCHEMBL29434697 0.83 ALDH1A1 (0.47) MEN1KMT2ASMN1; SMN2LMNAHPGD
SCHEMBL263603 0.82 NOTUM (0.44) RECQLSMN1; SMN2HPGDNPC1RAB9A
SCHEMBL1535743 0.79 IDO1 (0.38) MEN1KMT2ASMN1; SMN2LMNAHPGD
SCHEMBL507688 0.79 CYP4F2 (0.40) MEN1KMT2ASMN1; SMN2LMNAHPGD
SCHEMBL1045835 0.78 CA2 (0.38) RECQLTTRCYP2D6HSD17B10
SCHEMBL29875658 0.78 CA2 (0.38) RECQLTTRCYP2D6HSD17B10
SCHEMBL92905 0.78 IDO1 (0.58) RECQLSMN1; SMN2IDO1HSD17B10ALOX15
SCHEMBL257061 0.77 ALDH1A1 (0.42) MEN1KMT2ASMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4444697-A1 CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2024-10-16 EP disclosed
WO-2023107563-A1 CARBOXYLIC ACID CONTAINING INDANYL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES CELGENE CORPORATION (US) 2023-06-15 WO disclosed
EP-4081511-A1 CARBOXY DERIVATIVES WITH ANTIINFLAMMATORY PROPERTIES Sitryx Therapeutics Limited (GB) 2022-11-02 EP disclosed